Valuation: Optimax Holdings

Market Cap 285M 69.84M 61.16M 56.33M 52.29M 99.3M 6.66B 101M 674M 262M 3.27B 262M 257M 11.34B P/E 2026 *
18.4x
P/E 2027 * 16.3x
Enterprise Value 282M 69.08M 60.5M 55.72M 51.72M 98.22M 6.59B 99.55M 667M 260M 3.23B 259M 254M 11.21B EV / Sales 2026 *
1.86x
EV / Sales 2027 * 1.73x
Free-Float
23.9%
Yield 2026 *
3.01%
Yield 2027 * 3.5%
05-25 Maybank Research Downgrades Optimax Holdings to Hold from Buy; Price Target is MYR0.58 MT
05-22 Optimax Holdings Berhad Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-03 Optimax to Start Offering ENT Services Following Malaysian Health Ministry's Nod MT
03-02 Optimax Holdings Berhad Receives Approval from Ministry of Health to Offer Otorhinolaryngology (Ear, Nose and Throat) Services CI
02-27 Optimax Holdings Berhad Announces Second Interim Single-Tier Dividend on Ordinary Share, Payable 30 March 2026 CI
02-26 Optimax Holdings Berhad Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
11-26 Optimax Holdings Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
11-26 Optimax Holdings Berhad Announces Interim Single-Tier Dividend for the Year Ended 31 December 2025, Payable on 26 December 2025 CI
08/10/25 Hong Leong Investment Bank Starts Optimax Holdings at Buy with 0.96 Ringgit Price Target MT
27/08/25 Optimax Holdings Berhad Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
28/05/25 Optimax Holdings Berhad Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
27/02/25 Optimax Holdings Berhad Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 CI
27/02/25 Optimax Holdings Berhad Announces Interim Single-Tier Dividend for the Year Ended 31 December 2024, Payable on 28 March 2025 CI
1 month-0.94%
3 months+0.96%
6 months-9.48%
Current year-8.70%
1 week 0.52
Extreme 0.52
0.54
1 month 0.52
Extreme 0.52
0.54
Current year 0.5
Extreme 0.505
0.64
1 year 0.5
Extreme 0.5
0.72
3 years 0.46
Extreme 0.46
0.74
5 years 0.46
Extreme 0.46
0.84
10 years 0.3
Extreme 0.305
0.94
Manager TitleAgeSince
Chief Executive Officer 37 01/12/2019
Director of Finance/CFO 38 01/09/2018
Chief Operating Officer 37 01/01/2024
Director TitleAgeSince
Director/Board Member 81 01/12/2021
Chairman 65 01/12/2021
Director/Board Member 70 09/08/2018
Date Insider Type Main position Quantity % Market Cap.
06-03Buy

Chairman

97,000 0.0179%
05-29Buy

Chairman

3,000 0.0006%
18/04/25
Sena Healthcare Services Sdn. Bhd.
BuyCompany 674,000 0.1241%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%+2.94%-26.06% 69.84M
-2.52%-1.45%+51.39%+46.79% 130B
+1.60%+6.31%+10.75%+41.64% 92.52B
+1.67%+9.58%+3.23%+77.76% 27.78B
-1.05%+0.38%+20.65%+53.04% 23.63B
-0.37%+2.31%-19.79%-25.21% 20.29B
+1.21%+10.16%+20.23%+157.87% 17.76B
-2.10%+0.92%+0.20%+12.18% 14.9B
+0.34%+7.29%+65.34%+131.22% 15.13B
+2.66%+6.77%-11.81%-1.40% 12.63B
Average +0.14%+4.04%+14.31%+46.78% 35.5B
Weighted average by Cap. -0.39%+3.07%+25.54%+50.15%

Financials

2026 *2027 *
Net sales 152M 37.19M 32.57M 30M 27.84M 52.87M 3.55B 53.59M 359M 140M 1.74B 140M 137M 6.04B 157M 38.53M 33.75M 31.08M 28.85M 54.79M 3.68B 55.53M 372M 145M 1.8B 145M 142M 6.26B
Net income 15.65M 3.83M 3.36M 3.09M 2.87M 5.45M 366M 5.52M 37.01M 14.4M 179M 14.39M 14.08M 622M 17.6M 4.31M 3.77M 3.48M 3.23M 6.13M 411M 6.21M 41.61M 16.19M 202M 16.18M 15.83M 700M
Net Debt -3.1M -759K -665K -612K -568K -1.08M -72.4M -1.09M -7.33M -2.85M -35.54M -2.85M -2.79M -123M -12.4M -3.04M -2.66M -2.45M -2.27M -4.32M -290M -4.38M -29.32M -11.41M -142M -11.4M -11.15M -493M
Logo Optimax Holdings
Optimax Holdings Berhad is a Malaysia-based investment holding company offering eye specialist services. It has approximately seven satellite clinics/centers, 13 ambulatory care centers, one specialist hospital, and 288 staff/professional doctors. Its geographical segments include North Malaysia, Central Malaysia, South Malaysia, East Malaysia, and Cambodia. Its services are categorized into Refractive Surgery, Treatment of Eye Diseases and Disorders, Consultation and Dispensary Services, Oculoplastic Surgery, Plastic Surgery, and Aesthetic Services. Refractive Surgery includes laser and implant vision correction procedures. Treatment of Eye Diseases and Disorders includes cataract surgery and other medical interventions. Consultation and Dispensary Services cover doctor consultations and medication dispensing. Oculoplastic Surgery provides functional and cosmetic treatments around the eye. Its additional services include Eye Examinations, Sales of Optical Wear, and Laboratory Tests.
Employees
-
Date Price Change Volume
07/07/26 MYR 0.5250 0.00% 25,400
06/07/26 MYR 0.5250 0.00% 241,400
03/07/26 MYR 0.5250 -0.94% 62,500
02/07/26 MYR 0.5300 +0.95% 133,400
01/07/26 MYR 0.5250 0.00% 134,000
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
0.5250MYR
Average target price
0.6880MYR
Spread / Average Target
+31.05%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 0222 Stock